NASDAQ:CNCE
$8.39
(
0.720%
)
Friday, 27th Jan 2023
Concert Pharmaceuticals Stock Price (Quote)
Range | Low Price | High Price | Comment |
---|---|---|---|
30 days | $4.75 | $8.44 | Friday, 27th Jan 2023 CNCE stock ended at $8.39. This is 0.72% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 1.69% from a day low at $8.30 to a day high of $8.44. |
90 days | $4.20 | $8.44 | |
52 weeks | $2.57 | $8.44 |
Historical Concert Pharmaceuticals prices
Date | Open | High | Low | Close | Volume |
2023-01-27 | $8.30 | $8.44 | $8.30 | $8.39 | 1 174 325 |
2023-01-26 | $8.31 | $8.33 | $8.29 | $8.33 | 1 053 760 |
2023-01-25 | $8.28 | $8.32 | $8.27 | $8.31 | 2 098 921 |
2023-01-24 | $8.28 | $8.33 | $8.27 | $8.30 | 1 317 640 |
2023-01-23 | $8.28 | $8.33 | $8.27 | $8.28 | 1 923 933 |
2023-01-20 | $8.29 | $8.34 | $8.24 | $8.28 | 7 566 330 |
2023-01-19 | $8.24 | $8.33 | $8.22 | $8.29 | 56 942 300 |
2023-01-18 | $7.48 | $7.64 | $6.85 | $6.90 | 475 138 |
2023-01-17 | $7.05 | $7.56 | $6.96 | $7.40 | 663 843 |
2023-01-13 | $6.99 | $7.18 | $6.93 | $7.05 | 378 600 |
2023-01-12 | $6.74 | $7.28 | $6.64 | $7.11 | 529 142 |
2023-01-11 | $7.12 | $7.23 | $6.64 | $6.73 | 977 857 |
2023-01-10 | $7.26 | $7.81 | $6.88 | $7.10 | 906 720 |
2023-01-09 | $7.04 | $7.77 | $6.60 | $7.39 | 1 180 000 |
2023-01-06 | $6.25 | $7.90 | $6.12 | $7.49 | 1 480 900 |
2023-01-05 | $6.01 | $6.38 | $5.89 | $6.28 | 372 036 |
2023-01-04 | $5.98 | $6.13 | $5.82 | $5.99 | 343 743 |
2023-01-03 | $5.90 | $6.35 | $5.86 | $5.98 | 706 291 |
2022-12-30 | $5.33 | $5.90 | $5.24 | $5.84 | 707 498 |
2022-12-29 | $4.86 | $5.62 | $4.84 | $5.41 | 436 722 |
2022-12-28 | $4.78 | $4.91 | $4.75 | $4.87 | 145 174 |
2022-12-27 | $4.87 | $4.95 | $4.76 | $4.77 | 209 637 |
2022-12-23 | $4.90 | $4.99 | $4.75 | $4.87 | 243 967 |
2022-12-22 | $4.80 | $4.97 | $4.65 | $4.96 | 389 948 |
2022-12-21 | $4.66 | $4.84 | $4.56 | $4.82 | 191 535 |
2022-12-20 | $4.40 | $4.68 | $4.33 | $4.63 | 373 408 |
2022-12-19 | $4.68 | $4.72 | $4.28 | $4.40 | 342 942 |
2022-12-16 | $4.67 | $4.83 | $4.55 | $4.70 | 785 429 |
2022-12-15 | $4.55 | $4.72 | $4.53 | $4.71 | 309 770 |
2022-12-14 | $4.64 | $4.82 | $4.51 | $4.63 | 156 451 |
2022-12-13 | $4.91 | $4.98 | $4.56 | $4.67 | 348 172 |
2022-12-12 | $4.42 | $4.90 | $4.33 | $4.79 | 376 082 |
2022-12-09 | $4.44 | $4.62 | $4.41 | $4.45 | 251 652 |
2022-12-08 | $4.42 | $4.50 | $4.33 | $4.48 | 390 767 |
2022-12-07 | $4.52 | $4.55 | $4.20 | $4.34 | 256 638 |
2022-12-06 | $4.72 | $4.72 | $4.45 | $4.52 | 272 546 |
2022-12-05 | $4.84 | $5.11 | $4.70 | $4.76 | 439 058 |
2022-12-02 | $4.86 | $4.86 | $4.67 | $4.86 | 218 164 |
2022-12-01 | $4.83 | $5.07 | $4.82 | $4.93 | 311 523 |
2022-11-30 | $4.72 | $4.82 | $4.54 | $4.82 | 222 498 |
2022-11-29 | $4.98 | $5.12 | $4.72 | $4.75 | 221 750 |
2022-11-28 | $5.00 | $5.10 | $4.85 | $4.99 | 215 640 |
2022-11-25 | $5.13 | $5.20 | $5.07 | $5.08 | 31 974 |
2022-11-23 | $5.14 | $5.30 | $5.11 | $5.16 | 273 925 |
2022-11-22 | $4.83 | $5.14 | $4.77 | $5.14 | 318 050 |
2022-11-21 | $4.82 | $4.86 | $4.68 | $4.80 | 182 522 |
2022-11-18 | $4.74 | $4.92 | $4.64 | $4.81 | 108 545 |
2022-11-17 | $4.79 | $4.79 | $4.55 | $4.66 | 124 468 |
2022-11-16 | $4.92 | $4.95 | $4.73 | $4.76 | 147 194 |
2022-11-15 | $4.99 | $5.11 | $4.83 | $4.96 | 180 433 |
About Concert Pharmaceuticals
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologi... CNCE Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.